Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
8.21
-0.01 (-0.12%)
At close: Apr 9, 2026, 4:00 PM EDT
8.10
-0.11 (-1.34%)
After-hours: Apr 9, 2026, 4:43 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 858.00K | 636.00K | - | - | - | | |
Biotechnology (Startups) Growth | 34.91% | - | - | - | - | | |
| 858.00K | 636.00K | - | - | - | | |
| 34.91% | - | - | - | - | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 858.00K | 636.00K | - | - | - | | |
| 34.91% | - | - | - | - | | |
| 858.00K | 636.00K | - | - | - | | |
| 34.91% | - | - | - | - | | |
Source: S&P Global Market Intelligence.
